Predicting Left Ventricular Dysfunction in Childhood Cancer Survivors: In Search of the Echocardiography Holy Grail

William L Border; Karen E Effinger; Kasey J Leger

doi:10.1016/j.jaccao.2023.07.003

Predicting Left Ventricular Dysfunction in Childhood Cancer Survivors: In Search of the Echocardiography Holy Grail

JACC CardioOncol. 2023 Aug 15;5(4):486-488. doi: 10.1016/j.jaccao.2023.07.003. eCollection 2023 Aug.

Authors

William L Border¹, Karen E Effinger², Kasey J Leger³

Affiliations

¹ Department of Pediatrics, Emory University, Children's Healthcare of Atlanta Cardiology, Atlanta, Georgia, USA.
² Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
³ Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.

No abstract available

Keywords: alkylating therapy; anthracycline; cancer survivorship; cardiomyopathy; echocardiography; epidemiology; imaging; risk factor; screening.

Publication types

Editorial